why would any capable exec take on this basket case?
hope she has the connections for to get some deals done but seems a bit light in any licensing expertises or clinical trials or regulatory or manufacturing . Maybe the Tony Eglezes and Jeremy Paul can show her how not to do that.
I look forward to a good house clean in January of the deadwood jackyophiles that have milked the weak board.
Ann: Starpharma announces new CEO, Ms Cheryl Maley, page-21
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |